Moderate to Severe Glabellar Line
1 clinical trials · Condition
◉ Watch Moderate to Severe Glabellar Line
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line (NCT01629875) | Daewoong Pharmaceutical Co. LTD. | 2012-03-01 |
Track Moderate to Severe Glabellar Line automatically
Every clearance here is in the API, with alerts when new ones post.